Femasys Inc. (“Femasys”) products are protected by patents in the United States and elsewhere. This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including those described in the America Invents Act. The following list of Femasys products may not be all inclusive, and other Femasys products not listed here may be protected by one or more patents.
FemBloc®
Permanent Birth Control System
Patents Nos. 8,048,086; 8,048,101; 8,052,669; 8,316,853; 8,316,854; 8,324,193; 8,336,552; 8,695,606; 8,726,906; 9,034,053; 9,220,880; 9,308,023; 9,402,762; 9,839,444; 10,111,697; 10,292,732; 10,646,255; US D714,436, and pending applications.
FemChec®
Tubal Occlusion Confirmation Device
Patents Nos. 10,737,104; US D653,329; US D740,411; US D834,181, and pending applications.
FemaSeed™
Localized Directional Insemination System
Patents Nos. 9,238,127; US D654,583, and pending applications.
FemVue®
Fallopian Tube Evaluation Device
Patent Nos. 9,554,826; 10,070,888; 10,172,643; 10,258,375; US D660,957; US D672,456; US D709,184, and pending applications.
FemCerv®
Endocervical Tissue Sampler
Patents Nos. 9,788,820; US D692,134, and pending applications.
FemEMB™
Endometrial Tissue Sampler
Patents Nos. 9,655,600; 10,631,835, and pending applications.